-
ALPHAMAB, 3D Medicines, and Glenmark Reach $700 Million Licensing Agreement for KN035
In a significant development, ALPHAMAB Biopharmaceuticals, in collaboration with 3D Medicines, has announced a groundbreaking licensing agreement wort...
2024-01-25 14:52 -
Behind the Stock Price Plummet: The Rise and Fall of 'ADC China Dream Factory'
In the wake of a significant decline in stock prices, the spotlight has turned to the "ADC China Dream Factory" and its journey filled with both succe...
2024-01-25 14:50 -
NVIDIA's AI-Pharmaceutical Collaboration Marks a Pivotal Milestone
NVIDIA, a renowned technology company, experienced a remarkable day with its significant achievements in the field of AI-driven pharmaceuticals.
2024-01-25 14:48 -
Bankruptcy Liquidation of a Pharmaceutical Company in 2024
In a recent development that has sent shockwaves through the pharmaceutical industry, a biotechnology company has filed for bankruptcy liquidation.
2024-01-25 14:46 -
Unleashing the Potential of the Pharmaceutical Industry in 2024: A Futuristic Outlook
As we bid farewell to 2023, a year filled with remarkable advancements in the field of medicine, we stand at the threshold of 2024, a year brimming wi...
2024-01-25 14:45 -
Unveiling Certainties in China's Pharmaceutical Industry
The landscape of China's pharmaceutical industry has witnessed significant advancements in recent years, showcasing the innovation capabilities of dom...
2024-01-23 16:59 -
The Future of the Pharmaceutical Industry in 2024: Emerging Trends After the Darkest Hour
The pharmaceutical industry is poised for a transformative journey in 2024, as it emerges from a challenging period marked by uncertainty and setbacks...
2024-01-23 16:54 -
Groundbreaking Advancement in Colorectal Cancer: 'Immunotherapy Twin Stars' Reduce Disease Progressi...
In a significant breakthrough for the treatment of colorectal cancer, a recent clinical study has revealed remarkable results in reducing disease prog...
2024-01-23 16:43 -
Breakthrough in Cancer Treatment: AI-Powered Drug Discovery Shows Promising Results
In a significant development in the field of cancer treatment, researchers have made strides in leveraging artificial intelligence (AI) for drug disco...
2024-01-23 16:39 -
Disappointing Results in Phase III Clinical Trial for Gilead's Trop2 ADC in Non-Small Cell Lung Canc...
Gilead Sciences, a renowned pharmaceutical company, recently faced a setback as their Trop2 ADC (Antibody-Drug Conjugate) failed to meet the primary e...
2024-01-23 16:37
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- UBE Corporation Accelerates Ch... Jul 02, 2025
Related Products
Related Producers
